Nörolojik Bulguları Olan Primer İmmün Yetmezlik Hastalıkları
Özet
Primer immün yetmezlikler sadece bağışıklık sistemini değil, merkezi sinir sistemi dahil birçok organı etkileyebilen karmaşık genetik hastalıklardır. Bu hastalıklarda görülen nörolojik bulgular; enfeksiyonlar, otoimmünite, toksik metabolit birikimi veya genetik kusurların sinir hücreleri üzerindeki doğrudan etkilerinden kaynaklanabilir. Nörolojik belirtiler bazen hastalığın ilk işareti olarak ortaya çıkmakta ve hastaların mortalite ve morbiditesini doğrudan etkileyebilmektedir. Erken tanı ve farkındalığın artırılması, klinik yönetimin başarısı için kritik öneme sahiptir.
Primary immunodeficiency diseases are complex genetic conditions that can affect multiple organ systems beyond the immune system, including the central nervous system. Neurological manifestations in these patients may arise from various mechanisms, including infections, autoimmunity, toxic metabolite accumulation, or the direct impact of defective genes on neural cells. These neurological findings can sometimes serve as the initial clinical sign, playing a significant role in determining patient mortality and morbidity. Therefore, raising clinical awareness and achieving early diagnosis are essential for effectively managing these conditions.
Referanslar
Stuart G Tangye, Waleed Al-Herz, Aziz Bousfiha et al. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal of Clinical Immunology 2020 40:24–64.
Dehkordy SF, Aghamohammadi A, Ochs HD, Rezaei N. Primary immunodeficiency diseases associated with neurologic manifestations. J Clin Immunol. 2012;32:1-24.
Aziz Bousfiha, Leila Jeddane, Capucine Picard et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40(1):66-81.
Zahra Chavoshzadeh, Amir Hashemitari, Sepideh Darougar . Neurological Manifestations of Primary Immunodeficiencies. Iran J Child Neurol. Summer 2018 12:7-23.
Hershfield M. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy. Semin Hematol 1998; 35: 291-8.
Nofech-Mozes Y, Blaser SI, Kobayashi J, Grunebaum E, Roifman CM. Neurologic abnormalities in patients with adenosine deaminase deficiency. Pediatr Neurol. 2007;37:218-221.
Gaspar HB. Bone marrow transplantation and alternatives for adenosine deaminase deficiency. Immunol Allergy Clin North Am 2010;30:221-36.
Enders A, Fisch P, Schwarz K, et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol. 2006;176:5060-5068.
Thomas Altmann , Andrew R Gennery .DNA ligase IV syndrome; a review. Altmann and Gennery Orphanet Journal of Rare Diseases (2016) 11:137.
IJspeert H, Rozmus J, Schwarz K et al. XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. Blood 2016 4;128(5):650-9.
Lefton-Greif MA, Crawford TO, Winkelstein JA, et al. Oropharyngeal dysphagia and aspiration in patients with ataxia-telengiectasia. J Pediatr 2000;136:225-31.
Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A. Ataxia-telangiectasia: A review of clinical features and molecular pathology. Pediatr Allergy Immunol. 2019;30(3):277-288.
Katherine Schon, Nienke J.H. van Os, Nicholas Oscroft et al.Genotype, Extrapyramidal Features, and Severity of Variant Ataxia-Telangiectasia. Ann Neurol 2019;85:170–180.
Aydin, Ö. F., Anlar, B. Neurological Manifestations of Primary Immunodeficiency Diseases. Clinical Pediatrics. 2017 57: 761–774.
Erin RP Shull, Youngsoo Lee, Hironobu Nakane, et al. Differential DNA damage signaling accounts for distinct neural apopitotic responses in ATLD and NBS. Genes Dev 2009; 23: 171-80.
Digweed M, Sperling K. Nijmegen Breakage syndrome; clinical manifestation of defective response to DNA double strand breaks. DNA repair 2004;3:1207-17.
Chrzanowska KH, Gregorek H, Dembowska-Baginska B, Kalina MA and Digweed M. Nijmegen breakge syndrome (NBS). Orphanet J Rare Dis. 2012 28;7:13.
Maja Vukic, Lucia Daxinger .DNA methylation in disease: Immunodeficiency,Centromeric instability, Facial anomalies syndrome. Essays in Biochemistry (2019) 63 773–783.
Hagleitner MM, Lankester A, Maraschio P, et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet. 2008;45:93-99.
Machteld M. Oud, Paul Tuijnenburg, Maja Hempel et al.Mutations in EXTL3 Cause Neuro-immuno-skeletal Dysplasia Syndrome The American Journal of Human Genetics 100, 2017;2: 281–296.
Sullivan KE. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial syndrome. Immunol Allergy Clin North Am 2008; 32: 353-66.
Sara Şebnem Kılıç, Handan Aydoğan. DiGeorge Sendromu. Güncel Pediatri 2004; 2: 98-100.
Catherine M Biggs , Sevgi Keles , Talal A Chatila DOCK8 deficiency: Insights into pathophysiology, clinical features and management Clin Immunol 2017; 181:75-82.
Renner ED, Puck JM, Holland SM, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 2004; 144: 93-9.
Zeigner UH, Kobayashi RH, Cunningham-Rundles C, et al. Progresive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol. 2002;102:19-24.
Rudge P, Webster AD, Revesz T, et al. Encephalomyelitis in primary hypogammaglobulinaemia. Brain 1996; 119: 1-15.
Stinchcombe J, Bossi G, Griffiths GM. Linking albinism and immunity: the secrets of secretory lysosomes. Science 2004;305:55-9.
Misra VP, King RHM, Harding AE, Muddle JR, Thomas PK. Peripheral neuropathy in the Chediak-Higashi syndrome. Acta Neuropathol 1991; 81:354-8.
Zuhal Karalı,Sara Şebnem Kılıç.Chediak-Higashi Sendromu. Güncel Pediatri 2007; 5: 99-104.
Mottonen M, Lanning M, Saarinen UM. Allogenic bone marrow transplantation in Chediak-Higashi syndrome. Pediatr Hematol Oncol 1995; 12:55-9.
Wendy J. Introne, Wendy Westbroek, Andrew R. Cullinane et al. Neurologic involvement in patients with atypical Chediak-Higashi disease. Neurology® 2016;86:1320–1328.
Ménasché G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000;25:173-6.
Huizing M, Anikster Y, Gahl WA. Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic 2000; 1: 823-835.
Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010;6:137-154.
Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol. 2002; 39:82-8.
Germeshausen M, Grudzien M, Zeidler C, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood 2008;111:4954-7.
Carlsson G, van’t Hooft I, Melin M, et al. Central nervous system involvement in severe congenital neutropenia: Neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med 2008;264:388–400.
Etzioni A. Novel aspects of phagocytic cell disorders. Curr Opin Allergy Clin Immunol 2001;1: 535-40.
Özgür Kasapçopur, Kenan Barut, Sezgin Şahin, Amra Adroviç. Çocukluk Çağında Otoenflamatuar Hastalıklar Tanı Kitabı 2016.p.15-16.
Açarı C, Ünsal ŞE. Hiperimmünoglobulinemi D sendromu-Mevalonat kinaz eksikliği. Berdeli A, editör. Genetik Otoinflamatuar Hastalıklar Tanı Yöntemleri ve Tedavilerinde Yenilikler. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.25-30.
Hoffmann GF, Charpentier C, Mayatepek E, Mancini J, Leichsenring M, Gibson KM, et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics. 1993;91(5):915-21.
Yıldırım M, Ayvaz DC, Konuşkan B, et al. Neurologic Involvement in Primary Immunodeficieny Disorders. Journal of Child Neurology 2018;33(5):320-328.
H. Haluk Akar, Turkan Patiroglu, Basak N. Akyildiz et al. Silent brain infarcts in two patients with zeta chain-associated protein 70 kDa (ZAP70) deficiency. Clinical Immunology 158(1), 88-91.
Kiykim A, Ogulur I, Dursun E et al. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency. Allergy Clin Immunol Pract. 2019;7(8):2790-2800.
